• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同亚型的肺大细胞癌患者的治疗结果。

Treatment outcomes of patients with different subtypes of large cell carcinoma of the lung.

机构信息

Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan; Graduate Institute of Business and Management, Chang Gung University, Taoyuan, Taiwan.

Department of Information Management, Chang Gung University, Taoyuan, Taiwan.

出版信息

Ann Thorac Surg. 2014 Sep;98(3):1013-9. doi: 10.1016/j.athoracsur.2014.05.012. Epub 2014 Jul 29.

DOI:10.1016/j.athoracsur.2014.05.012
PMID:25085555
Abstract

BACKGROUND

Although large cell neuroendocrine carcinoma (LCNEC) and lymphoepithelioma-like carcinoma (LELC) are the variants of large cell carcinoma (LCC) of lung, there are few studies comparing them. The aim of this study was to compare the clinical characteristic and treatment outcomes of LCNEC, LELC, and classic LCC.

METHODS

Patients with LCNEC, LELC, or classic LCC were identified in a prospectively collected database, and their data were analyzed.

RESULTS

A total of 46 patients with classic LCC, 30 with LCNEC, and 18 with LELC, who received surgical resection with curative intent, were identified and included in the analysis. Patients with LELC were younger, and the frequency of nonsmokers was greater than in patients with classic LCC or LCNEC. In patients with LCNEC or LELC, most lesions were located on the left side. There were 5 surgical deaths, and the median follow-up time of the surviving patients was 44.1 months. The 5-year disease free survival among the three subgroups was similar (p = 0.601), but patients with LELC had a significantly better overall survival than the other two subgroups (LELC vs classic LCC, p = 0.009; LELC vs LCNEC, p = 0.002). Multivariate analysis showed tumor location site, tumor stage, and LELC were independent prognostic factors of overall survival.

CONCLUSIONS

The clinical manifestations and treatment outcomes of LCNEC, LELC, and classic LCC are different. LCNEC has a poor survival, and survival is not different than that of classic LCC. LELC is associated with younger age and a higher frequency of nonsmokers, and the treatment outcomes are better than those of other subtypes.

摘要

背景

虽然大细胞神经内分泌癌(LCNEC)和淋巴上皮样癌(LELC)是肺大细胞癌(LCC)的变体,但比较它们的研究很少。本研究旨在比较 LCNEC、LELC 和经典 LCC 的临床特征和治疗结果。

方法

在一个前瞻性收集的数据库中确定了 LCNEC、LELC 或经典 LCC 的患者,并对其数据进行了分析。

结果

共纳入 46 例接受根治性手术治疗的经典 LCC 患者、30 例 LCNEC 患者和 18 例 LELC 患者,并进行了分析。LELC 患者年龄较小,非吸烟者的比例高于经典 LCC 或 LCNEC 患者。在 LCNEC 或 LELC 患者中,大多数病变位于左侧。有 5 例手术死亡,存活患者的中位随访时间为 44.1 个月。三组患者的 5 年无病生存率相似(p = 0.601),但 LELC 患者的总生存率明显优于其他两组(LELC 与经典 LCC,p = 0.009;LELC 与 LCNEC,p = 0.002)。多因素分析表明肿瘤部位、肿瘤分期和 LELC 是总生存的独立预后因素。

结论

LCNEC、LELC 和经典 LCC 的临床表现和治疗结果不同。LCNEC 的生存率较差,与经典 LCC 无差异。LELC 与年轻和非吸烟的频率较高有关,治疗结果优于其他亚型。

相似文献

1
Treatment outcomes of patients with different subtypes of large cell carcinoma of the lung.不同亚型的肺大细胞癌患者的治疗结果。
Ann Thorac Surg. 2014 Sep;98(3):1013-9. doi: 10.1016/j.athoracsur.2014.05.012. Epub 2014 Jul 29.
2
Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.肺大细胞神经内分泌癌的围手术期辅助化疗的临床反应。
Anticancer Drugs. 2010 Jan;21(1):89-93. doi: 10.1097/CAD.0b013e328330fd79.
3
[Prognosis of surgically treated large cell neuroendocrine carcinoma].[手术治疗的大细胞神经内分泌癌的预后]
Kyobu Geka. 2011 Mar;64(3):187-90.
4
A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.肺外周、小细胞型高级神经内分泌肿瘤的临床病理研究:小细胞肺癌与大细胞神经内分泌癌的区别。
Eur J Cardiothorac Surg. 2012 Apr;41(4):841-6. doi: 10.1093/ejcts/ezr132. Epub 2011 Dec 21.
5
Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.肺大细胞神经内分泌癌:其在肺癌谱系中的地位。
Ann Thorac Surg. 2007 Aug;84(2):702-7. doi: 10.1016/j.athoracsur.2007.03.093.
6
The differences of biological behavior based on the clinicopathological data between resectable large-cell neuroendocrine carcinoma and small-cell lung carcinoma.可切除的大细胞神经内分泌癌与小细胞肺癌基于临床病理数据的生物学行为差异。
Clin Lung Cancer. 2013 Sep;14(5):535-40. doi: 10.1016/j.cllc.2013.04.003. Epub 2013 Jun 20.
7
Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.肺大细胞神经内分泌癌患者术后生存的预测因素。
Ann Thorac Surg. 2015 Mar;99(3):983-9. doi: 10.1016/j.athoracsur.2014.10.015. Epub 2015 Jan 14.
8
p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.p53免疫染色与切除的肺大细胞癌患者生存率降低相关,且与基因突变无关。
Braz J Med Biol Res. 2007 Aug;40(8):1045-53. doi: 10.1590/s0100-879x2006005000122.
9
Results of surgical resection for patients with large cell carcinoma of the lung.大细胞肺癌患者的手术切除结果。
Int J Surg. 2010;8(5):391-4. doi: 10.1016/j.ijsu.2010.06.003. Epub 2010 Jun 12.
10
Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.经活检诊断的不可切除高级别肺神经内分泌癌的临床特征。
Lung Cancer. 2012 Mar;75(3):368-73. doi: 10.1016/j.lungcan.2011.08.012. Epub 2011 Sep 13.

引用本文的文献

1
Pathogenesis and therapeutic implications of EBV-associated epithelial cancers.EB病毒相关上皮性癌的发病机制及治疗意义
Front Oncol. 2023 Oct 2;13:1202117. doi: 10.3389/fonc.2023.1202117. eCollection 2023.
2
Clinicopathological characteristics and cancer-specific prognosis of primary pulmonary lymphoepithelioma-like carcinoma: a population study of the US SEER database and a Chinese hospital.原发性肺淋巴上皮瘤样癌的临床病理特征及癌症特异性预后:一项基于美国监测、流行病学和最终结果(SEER)数据库及一家中国医院的人群研究
Front Oncol. 2023 May 19;13:1103169. doi: 10.3389/fonc.2023.1103169. eCollection 2023.
3
The Clinical Characteristics and Treatments for Large Cell Carcinoma Patients Older than 65 Years Old: A Population-Based Study.
65岁以上大细胞癌患者的临床特征与治疗:一项基于人群的研究。
Cancers (Basel). 2022 Oct 25;14(21):5231. doi: 10.3390/cancers14215231.
4
Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma.预测肺大细胞神经内分泌癌患者总生存期的列线图的开发与验证
Transl Cancer Res. 2020 Aug;9(8):4943-4957. doi: 10.21037/tcr-20-780.
5
Clinical characteristics and treatments of large cell lung carcinoma: a retrospective study using SEER data.大细胞肺癌的临床特征与治疗:一项使用监测、流行病学和最终结果(SEER)数据的回顾性研究
Transl Cancer Res. 2020 Mar;9(3):1455-1464. doi: 10.21037/tcr.2020.01.40.
6
Clinicopathological characteristics with , , genetic alternation and prognostic analysis of primary lymphoepithelioma-like carcinoma.原发性淋巴上皮瘤样癌的临床病理特征、 、 基因改变及预后分析
Transl Cancer Res. 2019 Oct;8(6):2350-2356. doi: 10.21037/tcr.2019.09.51.
7
Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma.大细胞神经内分泌癌和大细胞癌的分子特征与预后分析
Front Oncol. 2022 Jan 14;11:664397. doi: 10.3389/fonc.2021.664397. eCollection 2021.
8
Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma.原发性肺淋巴上皮瘤样癌的分子与临床特征
Front Mol Biosci. 2021 Oct 25;8:736940. doi: 10.3389/fmolb.2021.736940. eCollection 2021.
9
Molecular Pathology of Lung Cancer.肺癌的分子病理学
Cold Spring Harb Perspect Med. 2022 Mar 1;12(3):a037812. doi: 10.1101/cshperspect.a037812.
10
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities.肺大细胞神经内分泌癌:当前的治疗选择及未来潜在机遇
Front Oncol. 2021 Apr 15;11:650293. doi: 10.3389/fonc.2021.650293. eCollection 2021.